Shuaiwei Zhou

发表

Biomarker profiling for risk of future heart failure (HFpEF) development

C. Watson, K. McDonald, M. Ledwidge, 2021, Journal of Translational Medicine.

B-Type Natriuretic Peptide and Ventricular Dysfunction in the Prediction of Cardiovascular Events and Death in Hypertension

C. Watson, K. McDonald, M. Ledwidge, 2018, American journal of hypertension.

Heart Failure Virtual Consultation: bridging the gap of heart failure care in the community ‐ A mixed‐methods evaluation

C. Watson, K. McDonald, M. Ledwidge, 2017, ESC heart failure.

A systematic review of clinical prediction rules for the diagnosis of chronic heart failure

C. Watson, K. McDonald, M. Ledwidge, 2019, ESC heart failure.

Comparison of longitudinal change in sST2 vs BNP to predict major adverse cardiovascular events in asymptomatic patients in the community

J. Januzzi, C. Watson, K. McDonald, 2020, Journal of cellular and molecular medicine.

Effect of Sacubitril/Valsartan vs Valsartan on Left Atrial Volume in Patients With Pre–Heart Failure With Preserved Ejection Fraction

J. Dodd, C. Watson, K. McDonald, 2023, JAMA cardiology.

New‐onset heart failure in the STOP‐HF programme. Natriuretic peptide defines and tracks risk and enables earlier diagnosis of heart failure

C. Watson, K. McDonald, J. Gallagher, 2020, European journal of heart failure.

Biomarker profiling for risk of future heart failure (HFpEF) development

C. Watson, K. McDonald, M. Ledwidge, 2021, Journal of translational medicine.

A systematic review of clinical prediction rules for the diagnosis of chronic heart failure

C. Watson, K. McDonald, M. Ledwidge, 2019, ESC heart failure.

Alcohol consumption and heart failure: a dose-response meta-analysis.

M. Ledwidge, C. Reddin, Shuaiwei Zhou, 2024, The Cochrane database of systematic reviews.